Hydrochloric Acid

Hydrochloric Acid

SCHEMBL29401281

O=C([O-])c1ccc[n+](Cc2ccccc2)c1.[Cl-].[Na+]

nearest known ligand 0.66

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 1/20 0.46
NPSR1 Q6W5P4 1/20 0.66
L3MBTL1 Q9Y468 1/20 0.66
LMNA P02545 1/20 0.54
ALDH1A1 P00352 1/20 0.49
CA2 P00918 1/20 0.48
CA4 P22748 1/20 0.48
USP2 O75604 1/20 0.47
CYP2D6 P10635 1/20 0.47
BCHE P06276 1/20 0.46
HSP90AA1 P07900 3/20 0.44
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
PABPC1 P11940 1/20 0.40
ATM Q13315 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31124466 0.97 NPSR1 (0.69) NPSR1L3MBTL1LMNAALDH1A1CA2
SCHEMBL124993 0.97 NPSR1 (0.69) NPSR1L3MBTL1LMNAALDH1A1CA2
SCHEMBL124202 0.95 NPSR1 (0.68) NPSR1L3MBTL1LMNAALDH1A1CA2
SCHEMBL124204 0.95 NPSR1 (0.68) NPSR1L3MBTL1LMNAALDH1A1CA2
SCHEMBL5148115 0.90 L3MBTL1 (0.59) NPSR1L3MBTL1LMNAALDH1A1CA2
Hydrochloric Acid SCHEMBL2805432 0.85 NPSR1 (0.71) NPSR1L3MBTL1LMNAALDH1A1CYP2D6
Hydrochloric Acid SCHEMBL29676296 0.84 NPSR1 (0.69) NPSR1L3MBTL1LMNAALDH1A1CYP2D6
Hydrochloric Acid SCHEMBL6682577 0.84 NPSR1 (0.69) NPSR1L3MBTL1LMNAALDH1A1CYP2D6
Hydrochloric Acid SCHEMBL6682576 0.84 NPSR1 (0.69) NPSR1L3MBTL1LMNAALDH1A1CYP2D6
SCHEMBL125500 0.83 NPSR1 (0.73) NPSR1L3MBTL1LMNAALDH1A1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4744901-A1 ON-PRESS DEVELOPMENT TYPE PLANOGRAPHIC PRINTING PLATE ORIGINAL PLATE, METHOD FOR PRODUCING PLANOGRAPHIC PRINTING PLATE, PLANOGRAPHIC PRINTING METHOD, AND COMPOUND FUJIFILM Corporation (JP) 2026-05-20 EP disclosed
US-20260131567-A1 ON-PRESS DEVELOPMENT TYPE LITHOGRAPHIC PRINTING PLATE PRECURSOR, METHOD OF PREPARING LITHOGRAPHIC PRINTING PLATE, LITHOGRAPHIC PRINTING METHOD, AND COMPOUND FUJIFILM CORPORATION (JP) 2026-05-14 US disclosed
US-20260084408-A1 POSITIVE TONE LITHOGRAPHIC PRINTING PLATE PRECURSOR AND METHOD OF PREPARING LITHOGRAPHIC PRINTING PLATE FUJIFILM CORPORATION (JP) 2026-03-26 US disclosed
EP-4714657-A1 POSITIVE-WORKING LITHOGRAPHIC PRINTING PLATE PRECURSOR AND METHOD OF PREPARING LITHOGRAPHIC PRINTING PLATE FUJIFILM Corporation (JP) 2026-03-25 EP disclosed
WO-2025013910-A1 ON-PRESS DEVELOPMENT TYPE PLANOGRAPHIC PRINTING PLATE ORIGINAL PLATE, METHOD FOR PRODUCING PLANOGRAPHIC PRINTING PLATE, PLANOGRAPHIC PRINTING METHOD, AND COMPOUND 富士フイルム株式会社 2025-01-16 WO disclosed
US-11835503-B2 TMA-formation inhibitor treatment for elevated TMA-containing compound diseases THE CLEVELAND CLINIC FOUNDATION (US) 2023-12-05 US disclosed
CN-112714612-B Compositions comprising PVA and certain herbicides with improved properties 拜耳公司 2023-03-28 CN disclosed
US-20220254275-A1 SYSTEM AND A METHOD FOR PROVIDING POSITIVE REINFORCEMENT ON APPROPRIATE FOOD ITEMS VENUGOPAL KRISHNA SARATHY (US) 2022-08-11 US disclosed
US-20220065829-A1 TRIMETHYLAMINE-CONTAINING COMPOUNDS FOR DIAGNOSIS AND PREDICTION OF DISEASE NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2022-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260131567-A1 ON-PRESS DEVELOPMENT TYPE LITHOGRAPHIC PRINTING PLATE PRECURSOR, METHOD OF PREPARING LITHOGRAPHIC PRINTING PLATE, LITHOGRAPHIC PRINTING METHOD, AND COMPOUND LEF1, LARP1, RUVBL1 ACHE 4859/4885NPSR1 3527/4885L3MBTL1 151/4885
US-20260084408-A1 POSITIVE TONE LITHOGRAPHIC PRINTING PLATE PRECURSOR AND METHOD OF PREPARING LITHOGRAPHIC PRINTING PLATE SUN2, LEF1, LCP1 ACHE 4487/4885NPSR1 3795/4885L3MBTL1 3250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.